Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?

BACKGROUND: Androgen deprivation therapy (ADT) is an effective palliation treatment in men with advanced prostate cancer (PC). However, ADT has well documented side effects that could alter the patient’s health-related quality of life (HRQoL). The current study aims to test whether a genetic stratif...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Urol
Autori principali: Karunasinghe, Nishi, Zhu, Yifei, Han, Dug Yeo, Lange, Katja, Zhu, Shuotun, Wang, Alice, Ellett, Stephanie, Masters, Jonathan, Goudie, Megan, Keogh, Justin, Benjamin, Benji, Holmes, Michael, Ferguson, Lynnette R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4971639/
https://ncbi.nlm.nih.gov/pubmed/27485119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-016-0164-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi